Cytiva

Safety and Innovation: Navigating the Challenges of Antibody-Drug Conjugates

This eBook provides scientists with more information on antibody–drug conjugates (ADCs), allowing you to further your research in this field.

Sponsored • Whitepaper • Bioprocessing

How Biotechnological Advances are Transforming Monoclonal Antibody Production

This Article Collection aims to offer scientists a wealth of information on monoclonal antibody (mAb) therapy, enabling you to advance your research in this field.

News

Cytiva Boosts Biomanufacturing with Cevec Buy

US life sciences company Cytiva has acquired Germany’s Cevec Pharmaceuticals, a move Cytiva said would further strengthen its leading position in biomanufacturing solutions. Financial terms were not revealed.

News

Cytiva Invests in US Resins Expansion

Life science company Cytiva has acquired a chromatography resins factory in Muskegon, Michigan, USA, marking its first investment in new capacity outside its manufacturing base of Sweden.

Top-Feature

Aenova Holding GmbH

Small Molecules: Choosing a Strategic, Scalable, and De-Risked Development Path

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

BIO Deutschland e.V.

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

CHEManager c/o Wiley-VCH Verlag

Upcoming Virtual Events

Interview

Building Green Practices Across the Chemical Supply Chain

Driving Sustainability Through Collaboration

Together for Sustainability (TfS) is a pioneering, member-led initiative working to accelerate sustainable and resilient chemical supply chains. TfS President Jennifer Jewson discusses the origins of TfS, its evolving goals, its present-day challenges, and the initiative’s enduring impact and outlook for the future.

Cytiva